Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
168.00    3.25 (1.97%)
Bid:
158.50
Ask:
167.50
Spread: 9.00 (5.678%)
Market Cap: £1.44b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Hutchmed News

IN BRIEF: Hutchmed highlights positive lung cancer test results
20 Mar 2025

IN BRIEF: Hutchmed highlights positive lung cancer test results

Hutchmed China Ltd - Hong Kong-based biopharmaceutical firm - Results from the Savannah phase 2 trial showed savolitinib plus Tagrisso achieved a clin...

Hutchmed China celebrates kidney cancer treatment; swings to loss
19 Mar 2025

Hutchmed China celebrates kidney cancer treatment; swings to loss

(Alliance News) - Hutchmed China Ltd on Wednesday hailed results of a clinical trial evaluating its kidney cancer treatment in China, while it reporte...

Hutchmed renal cell carcinoma trial meets primary endpoint
19 Mar 2025

Hutchmed renal cell carcinoma trial meets primary endpoint

(Sharecast News) - Hutchmed China, alongside Innovent Biologics, announced on Wednesday that the FRUSICA-2 phase two and three clinical trial evaluati...

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China
14 Jan 2025

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Hutchmed (China) Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in China for adult ...

LONDON MARKET OPEN: Stocks green but "policy uncertainties mount"
14 Jan 2025

LONDON MARKET OPEN: Stocks green but "policy uncertainties mount"

(Alliance News) - Stock prices in London opened higher on Tuesday ahead of important US producer price inflation data due this afternoon.

Hutchmed announces progress, hits milestone with lung cancer treatment
2 Jan 2025

Hutchmed announces progress, hits milestone with lung cancer treatment

(Sharecast News) - Hutchmed China announced a number of advancements on Thursday, including a regulatory milestone for its lung cancer treatment and a...

Hutchmed China disposes of 45% stake in Shanghai joint venture
2 Jan 2025

Hutchmed China disposes of 45% stake in Shanghai joint venture

(Alliance News) - Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd to GP Health Ser...